Christal Mickle
Founder bei ZEVRA THERAPEUTICS, INC.
Vermögen: 772 508 $ am 31.03.2024
Profil
Christal M.
M.
Mickle is the founder and the Chief Development Officer at Zevra Therapeutics, Inc., a company founded in 2006.
Prior to her current position, she worked as a Research Associate at New River Pharmaceuticals, Inc. from 2002 to 2005.
Ms. Mickle holds a graduate degree from the University of Virginia, which was conferred in 2005, and an undergraduate degree from Virginia Polytechnic Institute & State University, which was conferred in 2001.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZEVRA THERAPEUTICS, INC.
0,32% | 22.03.2024 | 133 191 ( 0,32% ) | 772 508 $ | 31.03.2024 |
Aktive Positionen von Christal Mickle
| Unternehmen | Position | Beginn |
|---|---|---|
| ZEVRA THERAPEUTICS, INC. | Founder | 30.10.2006 |
Ehemalige bekannte Positionen von Christal Mickle
| Unternehmen | Position | Ende |
|---|---|---|
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Christal Mickle
| University of Virginia | Graduate Degree |
| Virginia Polytechnic Institute & State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZEVRA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
